Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome

The Journal of Pediatrics
Aaron CarrelDavid Allen


To determine the effect of growth hormone (GH) on body composition and motor development in infants and toddlers with Prader-Willi syndrome (PWS). Twenty-nine subjects with PWS (4-37 months of age) were randomized to GH treatment (1mg/m 2 /day) or observation for 12 months. Percent body fat, lean body mass, and bone mineral density were measured by dual x-ray absorptiometry; energy expenditure was measured by deuterium dilution; and motor constructs of mobility (M) and stability (S) were assessed using the Toddler Infant Motor Evaluation (TIME). GH-treated subjects, compared with controls, demonstrated decreased percent body fat (mean, 22.6% +/- 8.9% vs 28.5% +/- 7.9%; P < .001), increased lean body mass (mean, 9.82 +/- 1.9 kg vs 6.3 +/- 1.9 kg; P < .001), and increased height velocity Z scores (mean, 5. 0 +/- 1.8 vs 1.4 +/- 1.0; P < .001). Patients who began GH before 18 months of age showed higher mobility skill acquisition compared with controls within the same age range (mean increase in raw score, 284 +/- 105 vs 206 +/- 63; P < .05). GH treatment of infants and toddlers with PWS for 12 months significantly improves body composition and when begun before 18 months of age increases mobility skill acquisition. These results s...Continue Reading


Nov 1, 1990·Acta paediatrica Scandinavica·H CosteffJ Shaver
Apr 1, 1993·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·L J Miller, G H Roid
Dec 3, 1998·European Journal of Pediatrics·U EiholzerA Prader
Jan 8, 2000·Acta Paediatrica. Supplement·R D NichollsT A Gray
Mar 13, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·P S Davies
Jan 15, 2004·The Journal of Pediatrics·Guy Van VlietLuc L Oligny

❮ Previous
Next ❯


Aug 19, 2009·Reviews in Endocrine & Metabolic Disorders·Abigail B Wald, Naveen K Uli
Apr 7, 2010·International Journal of Pediatric Endocrinology·Gregory A HollmanAaron L Carrel
Oct 20, 2011·International Journal of Pediatric Endocrinology·Mary CatalettoBarbara Whitman
Aug 22, 2013·International Journal of Pediatric Endocrinology·Jill E Emerick, Karen S Vogt
Mar 13, 2008·The Journal of Clinical Endocrinology and Metabolism·Adda GrimbergMichael P Wajnrajch
Jan 12, 2010·The Journal of Clinical Endocrinology and Metabolism·Aaron L CarrelDavid B Allen
Apr 2, 2013·The Journal of Clinical Endocrinology and Metabolism·Cheri L DealUNKNOWN 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants
Jan 2, 2007·PLoS Genetics·David M Mutch, Karine Clément
Nov 11, 2008·Journal of Endocrinological Investigation·L A GondoniG Grugni
Feb 26, 2013·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·M G ButlerJ E Donnelly
Jun 2, 2012·Neuroscience and Biobehavioral Reviews·Linda ReusMaria W G Nijhuis-van der Sanden
Jul 9, 2011·Advances in Pediatrics·Bradley S Miller
Oct 1, 2010·International Journal of Pediatric Otorhinolaryngology·Michael A DeMarcantonioCraig S Derkay
Dec 1, 2015·American Journal of Medical Genetics. Part a·Lisa JohnsonMerlin G Butler
Dec 13, 2006·Best Practice & Research. Clinical Endocrinology & Metabolism·David M Mutch, Karine Clément
Feb 27, 2008·Journal of Intellectual Disability Research : JIDR·O DudleyF Muscatelli
Dec 19, 2007·International Journal of Paediatric Dentistry·Isabelle Bailleul-ForestierAnnick Vogels
Jul 5, 2006·Acta Paediatrica. Supplement·UNKNOWN WHO Multicentre Growth Reference Study Group
Jul 5, 2006·Acta Paediatrica. Supplement·UNKNOWN WHO Multicentre Growth Reference Study Group
Jun 21, 2013·Journal of Paediatrics and Child Health·Elly ScheermeyerCatherine S Y Choong
Jun 15, 2007·Child and Adolescent Psychiatric Clinics of North America·Fortu BenarrochVarda Gross-Tsur
Oct 29, 2008·Annales d'endocrinologie·F CastinettiT Brue
Jun 14, 2006·The Journal of Pediatrics·Adriana FranzeseGiuliana Valerio
Mar 28, 2006·Current Problems in Pediatric and Adolescent Health Care·Chris Plauche' JohnsonCynthia J Curry
Dec 17, 2014·Clinical Endocrinology·M CohenJ Hamilton
May 30, 2015·Pediatric Clinics of North America·Louisa Kalsner, Stormy J Chamberlain
Nov 9, 2010·Neuroscience and Biobehavioral Reviews·Linda ReusMaria W G Nijhuis-van der Sanden
Aug 19, 2014·International Journal of Pediatric Otorhinolaryngology·David J CrockettSteven L Goudy
Nov 15, 2006·American Journal of Medical Genetics. Part a·Susan E MyersDavid B Allen
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Peter C Hindmarsh, Mehul T Dattani
Aug 17, 2018·The Journal of Clinical Endocrinology and Metabolism·Stephany H DonzeAnita C S Hokken-Koelega
Dec 21, 2018·American Journal of Medical Genetics. Part a·Jennifer ProffittJune-Anne Gold
Aug 2, 2006·Treatments in Endocrinology·Ann C Lindgren
Nov 15, 2006·American Journal of Medical Genetics. Part a·Merlin G ButlerJoseph E Donnelly
Jan 19, 2008·American Journal of Medical Genetics. Part a·Graziano GrugniUNKNOWN Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (ISPED)
Sep 4, 2010·Current Opinion in Pulmonary Medicine·Oliviero BruniRaffaele Ferri
Nov 12, 2005·Pediatric Pulmonology·M PavoneRenato Cutrera

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.